ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 849,25
1,53%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sonnet BioTherapeutics Holdings Inc (SONN)

  7. Sonnet BioTherapeutics Holdings Inc (SONN) Actualités

SONN Sonnet BioTherapeutics Holdings Inc

1,8604
-0,0596 (-3,10%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Sonnet BioTherapeutics Holdings Inc SONN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0596 -3,10% 1,8604 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,97 1,809 1,97 1,8604 1,92
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
11/3/202412:30EDGAR2Form 8-K - Current report
14/2/202413:35EDGAR2Form 8-K - Current report
14/2/202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/2/202422:20EDGAR2Form 8-K - Current report
29/1/202422:15EDGAR2Form 8-K - Current report
05/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
02/1/202422:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
27/12/202322:56EDGAR2Form 8-K - Current report
22/12/202322:31EDGAR2Form S-3 - Registration statement under Securities Act of..
15/12/202322:30EDGAR2Form 8-K - Current report
14/12/202323:03EDGAR2Form 8-K - Current report
14/12/202323:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
17/11/202317:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/11/202317:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
28/10/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202315:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
19/10/202323:14EDGAR2Form S-1/A - General form for registration of securities..
04/10/202322:18EDGAR2Form S-1/A - General form for registration of securities..
28/9/202314:48EDGAR2Form S-1/A - General form for registration of securities..
19/9/202322:30EDGAR2Form S-1 - General form for registration of securities under..
19/9/202314:30EDGAR2Form 8-K - Current report
01/9/202314:30EDGAR2Form 8-K - Current report
31/8/202323:18EDGAR2Form 8-K - Current report
22/8/202314:30EDGAR2Form 8-K - Current report
22/8/202314:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/8/202322:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/8/202314:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202314:15EDGAR2Form 8-K - Current report
09/8/202322:34EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
07/8/202322:15EDGAR2Form DEF 14A - Other definitive proxy statements
07/8/202313:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
28/7/202322:31EDGAR2Form S-1 - General form for registration of securities under..
28/7/202322:30EDGAR2Form PRE 14A - Other preliminary proxy statements
17/7/202313:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/7/202313:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/6/202314:59EDGAR2Form 8-K - Current report
30/6/202314:40EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/6/202323:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]

Dernières Valeurs Consultées

NASDAQ
SONN
Sonnet BioTherapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés